AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Herpes Zoster Treatment Market by Treatment Type (Antiviral Medications, Anti Inflammatory Medications, and Others) Route Administration (Oral, and Topical) and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
... and Industry Forecast, 2021-2030 The global herpes zoster treatment market was valued at $217.09 million in 2020, and is projected to reach $303.42 million by 2030, registering a CAGR of 3.4% from 2021 to 2030. ... Read More
-
Progressive Multifocal Leukoencephalopathy - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Progressive Multifocal Leukoencephalopathy Understanding The ... Read More
-
Kaposi's Sarcoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Kaposi's Sarcoma Understanding The DelveInsight Kaposi's Sarcoma ... Read More
-
Syphilis - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Syphilis Understanding The DelveInsight Syphilis epidemiology report gives a ... Read More
-
Trichomoniasis – Epidemiology Forecast to 2032 (US)
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Trichomoniasis (US) Understanding The DelveInsight Trichomoniasis (US) ... Read More
-
Herpes Zoster Oticus - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Zoster Oticus Understanding The ... Read More
-
Herpes Zoster - Market Insight, Epidemiology and Market Forecast -2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Herpes Zoster market report provides current treatment practices, emerging drugs, Herpes Zoster market share of the individual therapies, current and forecasted Herpes Zoster ... Read More
-
AIDS Related Kaposi's Sarcoma - Market Insight, Epidemiology and Market Forecast -2032
... Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The AIDS Related Kaposi's Sarcoma market report provides current treatment practices, emerging drugs, AIDS Related Kaposi's Sarcoma market ... Read More
-
AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 AIDS Related Kaposi's ... Read More
-
HIV (Human Immunodeficiency Virus) - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HIV (Human Immunodeficiency ... Read More
-
Shingles - Market Insight, Epidemiology and Market Forecast -2032
... Spain, Italy, France, and United Kingdom) and Japan. The Shingles market report provides current treatment practices, emerging drugs, Shingles market share of the individual therapies, current and forecasted Shingles market Size from 2019 to 2032 ... Read More
-
Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast -2032
... Immunodeficiency Virus Type-1 (HIV-1) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Human Immunodeficiency Virus Type-1 (HIV-1) market report provides current treatment practices, emerging drugs, Human ... Read More
-
Women’s Health Diagnostics Market Segmentation by Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy & Fertility Testing, Sexually Transmitted Disease Testing, and Others); and by End User (Hospitals, Clinics, and Home Care) – Global Demand Analysis & Opportunity Outlook 2030
... Demand Analysis & Opportunity Outlook 2030 Market Overview Fatpos Global has released a report titled Women’s Health Diagnostics Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. ... Read More
-
Gonorrhea - Epidemiology Forecast - 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gonorrhea Understanding The DelveInsight Gonorrhea epidemiology report gives a ... Read More
-
Acquired Immunodeficiency Syndrome (AIDS) - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Acquired Immunodeficiency Syndrome ... Read More
-
Africa Condom Market, Size, Forecast 2022-2030, Industry Trends, Growth, Share, Impact of COVID-19, Opportunity Company Analysis
... to protect from SIT/ HIV diseases and unwanted pregnancies. In the Africa, most of countries are impoverished, and the awareness level of HIV/SIT diseases is negligible especially in its rural and semi-urban places. However the ... Read More
-
Genital Herpes - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Genital Herpes Understanding The DelveInsight Genital Herpes ... Read More
-
Herpes Simplex - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Simplex Understanding The DelveInsight Herpes Simplex ... Read More
-
Herpes Zoster - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Zoster Understanding The DelveInsight Herpes Zoster ... Read More
-
Cytomegalovirus (CMV) Infection - Market Insight, Epidemiology and Market Forecast -2032
... in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cytomegalovirus (CMV) Infection market report provides current treatment practices, emerging drugs, Cytomegalovirus (CMV) Infection market share of the individual therapies, ... Read More
-
HIV-associated Lipodystrophy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HIV-associated Lipodystrophy Understanding The DelveInsight HIV-associated Lipodystrophy ... Read More
-
Herpes Labialis - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Herpes Labialis Understanding The DelveInsight Herpes Labialis ... Read More
-
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Epidemiology Forecast - 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
HIV integrase inhibitors - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage HIV ... Read More
-
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Multi-Drug-Resistant (MDR) Neisseria ... Read More